Taking Stock: a Decade of Drug Policy a Civil Society Shadow Report - Executive Summary Taking Stock: a Decade of Drug Policy a Civil Society Shadow Report

Total Page:16

File Type:pdf, Size:1020Kb

Taking Stock: a Decade of Drug Policy a Civil Society Shadow Report - Executive Summary Taking Stock: a Decade of Drug Policy a Civil Society Shadow Report TAKING STOCK: A DECADE OF DRUG POLICY A CIVIL SOCIETY SHADOW REPORT - EXECUTIVE SUMMARY TAKING STOCK: A DECADE OF DRUG POLICY A CIVIL SOCIETY SHADOW REPORT Taking stock: A decade of drug policy Funded by: Open Society Foundations Robert Carr Fund Partnership to Inspire, Transform and Connect the HIV response (PITCH) project Global Fund to Fight AIDS, Tuberculosis and Malaria Copy editing: Kay Bailey Graphics and design: Report design: Mathew Birch Cover design: Rudy Tun-Sánchez Figures and infographics: Juan Fernandez Ochoa, IDPC Printing: Printech Europe © International Drug Policy Consortium Publication 2018 Taking stock: A decade of drug policy Foreword on Drug Policy Global Commission Credit: Global drug control policies have been based on the general principles of eliminating the production, trade or use of any illegal psychoactive substance from the world. Yet policies which seek to reach that objective have involved harsh law-enforcement and even militarisation. These end up affecting the most vulnerable people who use drugs, subsistence farmers involved in illegal crop cultivation and small-scale traffickers because they are easier to apprehend than are wealthy and well-connected people. The collateral damages are human rights and lives – those of the most vulnerable and those of the voiceless. To quote the Deputy High Commissioner for Human Rights (May 2018), in a world that is meant to be more inclusive and where no one should be left behind, ‘people who use drugs Rt Hon Helen Clark are not left behind. They are left outside’. strategy for the next ten years. But how can we A decade ago, the international community plan the future without a serious and far-ranging reiterated its aspiration to achieve a drug-free assessment of the past’s errors and successes? How world. Yet over that decade, available data shows can we quantify the unintended consequences of that the production, sale, and consumption of currently illegal drugs are soaring. So are the harms drug control policies when they are not evaluat- related to current policies, with dramatic increases ed? Up until now, no comprehensive evaluation in overdoses, prison overcrowding, HIV and has been carried out either on progress towards hepatitis transmission, a more revenue-generating achieving the 2009 targets or on the consequences and increasingly violent illegal market, and in the of the past decade in global drug control on human condoning by some of extrajudicial killings against rights, health, security, development, the environ- people who use drugs – killings that often take ment, and on the lives of the millions of affected place in broad daylight. people worldwide. Ten years after the world’s governments adopted at Furthermore, there is little appetite among countries the UN the Political Declaration and Plan of Action for such a review from the UN, proving once more on drugs, there is still little discussion on how to that drug policy remains mostly an ideological evaluate the impact of current policies, or on how issue rather than a societal topic that needs to be to analyse the results of the policies implemented addressed based on evidence, dialogue, and building during this period. In 2014, there was a mid-term consensus. In that vacuum, I welcome this Civil High-Level Review of the Political Declaration and Society Shadow Report in which the International Plan of Action. It resulted in a new negotiated Drug Policy Consortium which provides us with an document that reiterated the commitments, without excellent overview of the progress and the lack of providing any such ‘High-Level Review’. Two years it made in the last decade, as well as highlighting later, the 2016 UNGASS on drugs provided another the challenges and opportunities ahead – using all opportunity to review the current approach, to no existing government-based and UN-based data, avail. Although progress was made in bringing in along with scientific and grey literature. more visibility to issues related to health, human rights and development, the resulting Outcome What we learn from the shadow report is compel- Document failed to recognise the harmful ling. Since governments started collecting data consequences of the war on drugs approach. on drugs in the 1990s – based on the seizures of illegal substances, on the arrests of people who The international community is meeting again at a use drugs and their admission to treatment ser- Ministerial Segment at the Commission on Narcot- vices, and on the eradication of illegal crops – the ic Drugs in March 2019 to decide upon a common cultivation, consumption and illegal trafficking of Taking stock: A decade of drug policy Taking stock: A decade of drug policy i drugs have reached record levels. Moreover, current has driven countries to agree on the paths to drug policies are a serious obstacle to other social control drugs is breaking, both at the multilateral and economic objectives: progress on combating and at the regional levels. the HIV epidemic had been significant in the last 20 years, but is now stalled among people who It is our hope, at the Global Commission on Drug inject drugs; prison overcrowding has worsened, Policy, that the next decade in global drug policy with a fifth of the world’s inmates being arrested will align with the 2030 Agenda for Sustainable for drug-related offences and mostly for drug use Development to alleviate the pain and suffering of alone; and the ‘war on drugs’ has resulted in mil- millions of people affected by current drug policies, lions of people murdered, disappeared, or internally with the objective of leaving no one behind. By displaced. As the situation stands today, the major providing the most comprehensive assessment Sustainable Development Goals that concern gen- of the past lost decade, I am certain that this Civil der equality, the protection of the environment, Society Shadow Report will greatly contribute to socioeconomic development, and the reduction of the global drug control debates and ensure that violence and corruption will not be achieved for an the coming decade will be better embedded in important part of the population because of current the international community’s priorities of human drug policies. rights, development, peace and security. But there is still hope for a better outcome and for the international community to do better during Rt Hon Helen Clark the 2019 high-level meeting. While the possibility Member of the Global Commission on Drug Policy of building a new negotiated political declaration Former Prime Minister of New Zealand, 1999-2008 and plan of action is unlikely with the lack of any Former Administrator of the United Nations Development monitoring and assessment apart from the current Programme, 2009-2017 Shadow Report, the Vienna-based consensus that ii Taking stock: A decade of drug policy Table of contents Foreword i Acknowledgements 5 Abbreviations 6 Executive summary 7 Part 1: Introduction 15 1 Background 16 1.1 The UNGASS decade: ‘A drug-free world, we can do it’ 16 1.2 The 10-year review of the 1998 Political Declaration 18 1.3 The 2009 Political Declaration and Plan of Action: Setting a new target date 18 1.4 The 2014 mid-term review of the 2009 Political Declaration: A missed opportunity 19 1.5 The 2016 UNGASS: The winds of change 20 1.6 The next step: The 2019 Ministerial Segment of the 62nd CND 22 2 Objective of this shadow report 23 3 Methodology 24 Part 2: Evaluating progress made in addressing the ‘world drug problem’ since the adoption of the 2009 Political Declaration and Plan of Action 25 1 Assessing progress made against Article 36 of the 2009 Political Declaration 26 1.1 The illicit cultivation of opium poppy, coca bush and cannabis plant 26 1.2 The illicit demand for narcotic drugs and psychotropic substances; and drug-related health and social risks 29 1.3 The illicit production, manufacture, marketing and distribution of, and trafficking in, psychotropic substances, including synthetic drugs 30 1.4 The diversion of and illicit trafficking in precursors 31 1.5 Money-laundering related to illicit drugs 32 2 Assessing progress made towards the 2009 Plan of Action against the broader priorities of the United Nations 34 2.1 Protecting human rights 34 2.1.1 The right to highest attainable standard of health 34 2.1.2 The right to enjoy the benefits of scientific research 55 2.1.3 The right to life 57 2.1.4 The right to be free from torture and other cruel, inhuman and degrading treatment or punishment 58 2.1.5 The right to liberty and to be free from arbitrary detention 63 2.1.6 The right to a fair trial and due process 66 2.1.7 The rights of indigenous peoples 66 2.1.8 The right to be free from discrimination 67 Taking stock: A decade of drug policy Taking stock: A decade of drug policy 1 2.2 Promoting peace and security 70 2.2.1 The ‘balloon effect’ and escalating levels of violence 70 2.2.2 The rise of crypto-drug markets 72 2.2.3 Tackling Money Laundering 75 2.3 Advancing development 78 2.3.1 Analysing factors leading to illegal cultivation 78 2.3.2 Promoting sustainable development in cultivation and trafficking areas 81 2.3.3 Support and cooperation for alternative development 83 2.3.4 Ensuring collaboration with local communities in illegal crop cultivation areas 84 2.3.5 Protecting the environment in drug control strategies 86 2.3.6 Ensuring that development assistance protects human rights 87 Part 3: What next: Designing new benchmarks for global drug policy 89 1 The UNGASS Outcome Document as a policy framework beyond 2019
Recommended publications
  • Actors and Incentives in Cannabis Policy Change: an Interdisciplinary Approach to Legalization Processes in the United States and in Uruguay
    1 UNIVERSIDADE DE SÃO PAULO INSTITUTO DE RELAÇÕES INTERNACIONAIS Fernanda Mena Actors and incentives in cannabis policy change: an interdisciplinary approach to legalization processes in the United States and in Uruguay São Paulo 2020 FERNANDA MELLO MENA 2 Actors and incentives in cannabis policy change: an interdisciplinary approach to legalization processes in the United States and in Uruguay Original Version Ph.D. Thesis presented to the Graduate Program in International Relations at the International Relations Institute, Universidade de São Paulo, Brazil, to obtain the degree of Doctor in Science. Advisor: Prof. Dr. Leandro Piquet Carneiro São Paulo 2020 Autorizo a reprodução e divulgação total ou parcial deste trabalho, por qualquer meio convencional ou eletrônico, para fins de estudo e pesquisa, desde que citada a fonte. 3 Catalogação na Publicação* Instituto de Relações Internacionais da Universidade de São Paulo Mena, Fernanda Actors and incentives in cannabis policy change: an interdisciplinary approach to legalization processes in the United States and in Uruguay / Fernanda Mello Mena -- Orientador Leandro Piquet Carneiro. São Paulo: 2020. 195p. Tese (doutorado). Universidade de São Paulo. Instituto de Relações Internacionais. 1. Relações exteriores (História) – Brasil 2. Relações internacionais (História) - Brasil 3. Política externa – Brasil I. Mena, Fernanda II. Actors and incentives in cannabis policy change: an interdisciplinary approach to legalization processes in the United States and in Uruguay CDD 327.81 4 MENA, Fernanda Actors and incentives in cannabis policy change: an interdisciplinary approach to legalization processes in the United States and in Uruguay Ph. D. Thesis presented to the International Relations Institute, at the University of São Paulo, Brazil, to obtain the degree of Doctor in Science.
    [Show full text]
  • Report of the International Narcotics Control Board for 2015 (E/INCB/2015/1) Is Supple- Mented by the Following Reports
    INTERNATIONAL NARCOTICS CONTROL BOARD REPORT REPORT 2015 INTERNATIONAL NARCOTICS CONTROL BOARD CONTROL NARCOTICS INTERNATIONAL Report 2015 EMBARGO Observe release date: Not to be published or broadcast before Wednesday, 2 March 2016, at 1100 hours (CET) UNITED NATIONS CAUTION Reports published by the International Narcotics Control Board in 2015 TheReport of the International Narcotics Control Board for 2015 (E/INCB/2015/1) is supple- mented by the following reports: Report of the International Narcotics Control Board on the Availability of Internationally Controlled Drugs: Ensuring Adequate Access for Medical and Scientific Purposes (E/INCB/2015/1/Supp.1) Narcotic Drugs: Estimated World Requirements for 2016—Statistics for 2014 (E/INCB/2015/2) Psychotropic Substances: Statistics for 2014—Assessments of Annual Medical and Scientific Requirements for Substances in Schedules II, III and IV of the Convention on Psychotropic Substances of 1971 (E/INCB/2015/3) Precursors and Chemicals Frequently Used in the Illicit Manufacture of Narcotic Drugs and Psychotropic Substances: Report of the International Narcotics Control Board for 2015 on the Implementation of Article 12 of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988 (E/INCB/2015/4) The updated lists of substances under international control, comprising narcotic drugs, psychotropic substances and substances frequently used in the illicit manufacture of narcotic drugs and psychotropic substances, are contained in the latest editions of the annexes to the statistical forms (“Yellow List”, “Green List” and “Red List”), which are also issued by the Board. Contacting the International Narcotics Control Board The secretariat of the Board may be reached at the following address: Vienna International Centre Room E-1339 P.O.
    [Show full text]
  • WHO Cannabis Rescheduling and Its Relevance for the Caribbean
    Briefing paper August 2020 WHO cannabis rescheduling and its relevance for the Caribbean By Vicki J. Hanson, Pien Metaal and Dania Putri* Executive Summary • Actively engage with CND members, in particular Jamaica, the only English-speaking Following its first-ever critical review of Caribbean member of CND, emphasising cannabis, in January 2019 the World Health the urgent nature of recommendations 5.1 Organization (WHO) issued a collection of formal and 5.4. recommendations to reschedule cannabis and • Actively engage in relevant meetings and cannabis-related substances. 53 member states processes at the CND level, as well as of the Commission on Narcotic Drugs (CND), two emphasising the need for further follow- of which are Caribbean states, are set to vote on these recommendations in December 2020. ups to the critical review. • Actively engage and encourage support from Among the WHO’s recommendations, two other Caribbean governments and other key in particular appear to be the most urgent stakeholders such as CARICOM and OECS, and relevant for Caribbean countries: as well relevant civil society organisations, namely recommendation 5.1 (concerning experts, and affected communities. the acknowledgment of cannabis’ medicinal usefulness) and recommendation 5.4 (concerning Background: Cannabis and the the need to remove the term ‘extracts and UN drug scheduling system tinctures of cannabis’ from the 1961 Convention). Supporting these two recommendations Around the world, most national legislations presents an opportunity for Caribbean relating to the consumption, production, and governments and civil society to decolonise distribution of cannabis and cannabis-related drug control approaches in the region, as well substances are rooted in the current global drug as to strengthen the international legal basis for control system as institutionalised by the three 1 emerging medicinal cannabis programmes in main UN drug conventions.
    [Show full text]
  • Medical Cannabis Latin America & Caribbean
    MEDICAL CANNABIS LATIN AMERICA & CARIBBEAN SPECIAL REPORT 17 56 59 72 CULTIVATING BUSINESS PHARMACEUTICAL & MEDICAL SERVICES & TECHNOLOGY EVENTS Progressive, inclusive medical CBD popularity is surging across The medical cannabis industry A robust events industry cannabis policies can have a the continent as regulatory is birthing a range of secondary has grown around the significant social impact regimes jump to legalize it services across the region medical cannabis sector Image: Nader Ahmed, IndicaOnline Contents 1 FROM THE EDITOR’S DESK Managing Director LATAM Han Le Regional Director LATAM Federica Fermo Country Managers Blanca Bañares, Giulia Di Loreto THE BUSINESS YEAR: Country Editors Alejandra Gómez Arreola, Juan Pablo Vásquez Pedraza, Juan Manuel Mejía Salazar, Enrique José García, MEDICAL CANNABIS Daniel Alarcón Project Assistant LATIN AMERICA Angie Serrato Chief Executive Officer Ayşe Hazır Valentin Editor-in-Chief & CARIBBEAN Peter Howson Senior Editor Terry Whitlam Writer/Editor SPECIAL REPORT Evan Pheiffer Associate Editor Liz Colavita Chief Sub-Editor Shireen Nisha Sub-Editors Kabir Ahmad, Alia Kıran Editorial Coordinator Belemir Ece Çolak Web Editor Aidan McMahon Web Assistant & Social Media Coordinator Ahsen Durukan Web Developer Volkan Görmüş Assistant Web Developer Zişan Yalçınkaya Analytics Assistant Sena Özcanlı Art Director Emily Zier-Ünlü Junior Art Director Emre Boduç Senior Motion Graphic Designer Serkan Yıldırım he Business Year’s Special Report on market, and as the ideal exporter to its neigh- Motion Graphic Designer Medical Cannabis in Latin America bor and largest cannabis (medical or other- Yiğit Yeşillik T Senior Graphic Designers and the Caribbean is the second entry wise) market, the US, but has yet to clear the fi- Bilge Saka, Şule Kocakavak in our medical cannabis series, building upon nal obstacles in the country’s legal process and Contributors our inaugural report on the Colombian market.
    [Show full text]
  • A Multifaceted Approach to Address Variation in Cannabis Sativa
    University of Northern Colorado Scholarship & Creative Works @ Digital UNC Dissertations Student Research 5-2019 A Multifaceted Approach to Address Variation in Cannabis Sativa Anna Louise Schwabe Follow this and additional works at: https://digscholarship.unco.edu/dissertations Recommended Citation Schwabe, Anna Louise, "A Multifaceted Approach to Address Variation in Cannabis Sativa" (2019). Dissertations. 554. https://digscholarship.unco.edu/dissertations/554 This Text is brought to you for free and open access by the Student Research at Scholarship & Creative Works @ Digital UNC. It has been accepted for inclusion in Dissertations by an authorized administrator of Scholarship & Creative Works @ Digital UNC. For more information, please contact [email protected]. © 2019 ANNA LOUISE SCHWABE ALL RIGHTS RESERVED UNIVERSITY OF NORTHERN COLORADO Greeley, Colorado The Graduate School A MULTIFACETED APPROACH TO ADDRESS VARIATION IN CANNABIS SATIVA A Dissertation Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Anna Louise Schwabe College of Natural and Health Sciences School of Biological Sciences Biological Education May 2019 This Dissertation by: Anna Louise Schwabe Entitled: A Multifaceted Approach to Address Variation in Cannabis sativa has been approved as meeting the requirement for the Degree of Doctor of Philosophy in College of Natural and Health Sciences in School of Biological Sciences, Program of Biological Education. Accepted by the Doctoral Committee ____________________________________________________
    [Show full text]
  • Development of a Business Model for ABS in the Caribbean Region
    Development of Business Model for Access and Benefit Sharing in the Caribbean Region I Development of a Business Model for ABS in the Caribbean Region This report is prepared by Environmental Governance Consulting (EGC) under the auspices of the International Union for Conservation of Nature, Regional Office for Mexico, Central America and the Caribbean (IUCN-ORMACC) in collaboration with the Governments of Antigua and Barbuda, Barbados, Grenada, Guyana, Jamaica, St Kitts and Nevis, Saint Lucia and Trinidad and Tobago through their designated National Biodiversity Focal Point. Disclaimer This report was prepared by Environmental Governance Consulting (EGC) at the request of the International Union of Conservation of Nature (IUCN). The statements, observations, analysis, conclusions and recommendations are those of EGC. None of the statements contained in this report are intended to establish any obligation, standard or procedure by or on behalf of IUCN or any relevant parties mentioned in this report. By virtue of publishing this report, there is no obligation to adopt any of the recommendations set forth in the report. Citation Environmental Governance Consulting (2019) Development of a Business Model for Access and Benefit Sharing in the Caribbean Region, Prepared for IUCN, San Jose Costa Rica, 78 pages II Table of Contents List of Tables …………………………………………………………………………………………………………………… III List of Figures …………………………………………………………………………………………………………………… III Abbreviations and Acronyms …………………………………………………………………………………………… VI Executive Summary
    [Show full text]
  • National Strategic Framework on Health and Drugs a Comprehensive Approach to Address Health, Social and Legal Consequences of Drug Use in Myanmar
    National Strategic Framework on Health and Drugs A Comprehensive Approach to Address Health, Social and Legal Consequences of Drug Use in Myanmar 2020 Contents FOREWORD 1 ACKNOWLEDGEMENTS 3 ACRONYMS 5 EXECUTIVE SUMMARY 7 INTRODUCTION 17 Rationale for the development of the National Strategic Framework on Health and Drugs 19 The scope of the NSF on Health and Drugs 20 Process for the development of the NSF 20 Geopolitical context of The Republic of the Union of Myanmar 21 Determinants of drug use 22 Overview of health, social and legal consequences of drug use 24 Prevalence and patterns of drug use in Myanmar 28 Overview of risk factors for HIV in Myanmar 29 Epidemiology of HIV, and coinfections with viral hepatitis and tuberculosis 31 Alignment of the NSF with international and regional resolutions and declarations 34 Alignment of the NSF with national policies, strategies and plans 36 Relevant sectors and ministries 39 STRATEGIC DIRECTION 1. PRIMARY PREVENTION OF DRUG USE 41 Definition and introduction 43 Effectiveness of prevention of drug use: global evidence 44 Prevention of drug use in Myanmar 46 Challenges and gaps in drug use prevention 49 RECOMMENDATIONS FOR THE STRATEGIC DIRECTION 1 51 STRATEGIC DIRECTION 2. HARM REDUCTION 57 Definition and introduction 59 Preventing injection drug use initiation 62 Addressing health consequences of drug use in Myanmar 63 Overview of the harm reduction response in Myanmar 64 Funding for HIV and harm reduction response 66 Implementation of the harm reduction response in Myanmar 67 Overview of the status of implementation of the comprehensive harm reduction package 68 Interventions aimed at preventing sexual transmission among PWID and their sexual partners 73 Harm reduction in prisons 75 Harm reduction in the context of ATS use 76 Drug use among women 78 Challenges and gaps in harm reduction 78 RECOMMENDATIONS FOR THE STRATEGIC DIRECTION 2 82 STRATEGIC DIRECTION 3.
    [Show full text]
  • Fire and Ice: Conflict and Drugs in Myanmar’S Shan State
    Fire and Ice: Conflict and Drugs in Myanmar’s Shan State Asia Report N°299 | 8 January 2019 Headquarters International Crisis Group Avenue Louise 149 • 1050 Brussels, Belgium Tel: +32 2 502 90 38 • Fax: +32 2 502 50 38 [email protected] Preventing War. Shaping Peace. Table of Contents Executive Summary ................................................................................................................... i I. Introduction ..................................................................................................................... 1 II. A Long Legacy ................................................................................................................... 3 III. A New Drug Dynamic ....................................................................................................... 6 A. A Surge in Production ................................................................................................ 6 B. Tip of the Iceberg ....................................................................................................... 10 IV. The Links Between Drugs and Conflict ............................................................................ 12 A. Current Conflict Dynamics ........................................................................................ 12 B. The Role of the Drug Trade in the Conflict................................................................ 13 C. Ethno-political Clashes, Anti-drug Raids or Bank Heists? ....................................... 15 D. Why Is There Not
    [Show full text]
  • Cannabis Industry and Edibles
    CANNABIS INDUSTRY AND EDIBLES LABOUR MARKET REPORT ABOUT US Food Processing Skills Canada (FPSC) is the food and beverage manufacturing industry’s workforce development organization. As a non-profit, located in Ottawa with representatives across Canada, we support food and beverage manufacturing businesses from coast to coast in developing skilled and professional employees and workplace environments. Our work directly and positively impacts industry talent attraction, workforce retention and employment culture. We care about assisting the industry in finding, training and retaining the very best people for the job. Through our partnerships with industry, associations, educators and all levels of This project was funded by the Government of Canada’s Sectoral Initiatives Program. governments in Canada, FPSC has developed exceptional resources for The opinions and interpretations in this publication are those of the author and do not the sector including the Food Skills Library™, Canadian Food Processors necessarily reflect those of the Government of Canada. Institute™, FoodCert™ and Labour Market Information Reports. ISBN 978-1-989541-56-2 Copyright © 2020 Food Processing Skills Canada All rights reserved. The use of any part of this publication, whether it is reproduced, stored in a retrieval system or transmitted in any form or by any means (including electronic, mechanical, photographic, photocopying or recording), without the prior written permission of the Food Processing Skills Canada is an infringement of copyright law. Food Processing
    [Show full text]
  • Dissertation Submitted As Part of the Requirement for the Bsc Biological Science
    Faculty of Science & Technology The beliefs and attitudes of key populations in the UK in regards to whether cannabis should be legalised for medicinal purpose. A dissertation submitted as part of the requirement for the BSc Biological Science. C. R. Miles 12th May 2017 Word count: 10,749 Abstract Background Cannabis has been used for its therapeutic properties for five millennia and was prescribed for medicinal use in the UK until 1971. Cannabis then became classified as a Class B, Schedule 1 drug under the Misuse of Drugs Act 1971, which declared it has “no medicinal value”. However, since then a growing body of evidence derived from clinical trials and case reports have supported the plants claimed therapeutic potential. Consequently, many campaign for the legalisation of cannabis for medicinal use in the UK. Given this is a topic of much current debate, this study explores the views and concerns of the key sectors of UK populations, including healthcare professionals, politicians, lawyers, and students, as well as the general British public, in regards to the legalisation of medicinal cannabis in the UK. Method An anonymous online survey was created using SurveyMonkey. Healthcare professional, lawyers and politicians were contacted via email (contact details found on online websites). Students were targeted through social media and a paper survey which was handed out in Bournemouth University lectures. Members of the general public were also targeted through social media and a paper survey which was handed out in Bournemouth Town Centre. There was representative sample of 392 respondents. Results A statistically significant proportion (70%) of the key UK populations (as defined by this study) believe cannabis should be legalised for medicinal use.
    [Show full text]
  • PDF (Drug Policy and the Sustainable Development Agenda)
    POSITION PAPER DRUG POLICY AND THE SUSTAINABLE DEVELOPMENT AGENDA September 2018 KOFI ANNAN (IN MEMORIAM) JOYCE BANDA PAVEL BÉM RICHARD BRANSON FERNANDO HENRIQUE Chairman of the Kofi Annan Former President of Malawi Former Mayor of Prague, Entrepreneur, founder of the CARDOSO Foundation and Former Czech Republic Virgin Group,co-founder of Former President of Brazil Secretary-General of the The Elders, United Kingdom (Founding Chair) United Nations, Ghana MARIA CATTAUI HELEN CLARK NICK CLEGG RUTH DREIFUSS (CHAIR) CESAR GAVIRIA Former Secretary-General Former Prime Minister of New Former Deputy Former President of Former President of Colombia of the International Chamber Zealand and Administrator of Prime Minister of the Switzerland (Chair) of Commerce, Switzerland the United Nations United Kingdom Development Programme ANAND GROVER MICHEL KAZATCHKINE ALEKSANDER KWASNIEWSKI RICARDO LAGOS OLUSEGUN OBASANJO Former UN Special Rapporteur Former Executive Director of Former President of Poland Former President of Chile Former President of Nigeria on the right to health, India the Global Fund to Fight AIDS, Tuberculosis and Malaria, France GEORGE PAPANDREOU JOSÉ RAMOS-HORTA JORGE SAMPAIO GEORGE SHULTZ JAVIER SOLANA Former Prime Minister of Former President of Timor-Leste Former President of Portugal Former Secretary of State of Former European Union Greece the United States of America High Representative for the (Honorary Chair) Common Foreign and Security Policy, Spain MARIO VARGAS2 LLOSA PAUL VOLCKER ERNESTO ZEDILLO Writer and public intellectual,
    [Show full text]
  • Pioneering Past and Bright of Impactful Research and Scholarly
    TABLE OF CONTENTS HISTORY OF UTECH, JA 04 VISION & MISSION STATEMENT 05 FOREWORD 06 INTRODUCTION 07- 09 UTECH, JAMAICA’S RESEARCH MANAGEMENT ECOSYSTEM 10 - 15 A PIONEERING PAST AND A BRIGHT FUTURE 16 - 123 OF IMPACTFUL RESEARCH AND SCHOLARLY ACHIEVEMENTS RESEARCH ETHICS 17 - 19 THE BUILT ENVIRONMENT 20 - 31 BUSINESS, TOURISM & HOSPITALITY 32 - 43 )HUMAN IMMUNODEFICIENCY VIRUS HIV 44 - 50 OTHER INFECTIOUS DISEASES & NON-COMMUNICABLE DISEASES 51 - 58 AND FOOD CONSUMPTION, AFFORDABILITY & SECURITY PHARMACOLOGY & PHARMACEUTICS 59 - 62 )CANNABIS SATIVA )MARIJUANA/GANJA 63 - 68 CANCER AND MEDICINAL PLANTS 69 - 72 ENGINEERING, ICT APPLICATIONS & INFORMATION SYSTEMS 73 - 86 ORAL AND PUBLIC HEATLH 87 - 89 ,EDUCATION 90 - 104 HUMANITIES& SOCIAL SCIENCES MARINE BIOLOGY 105 - 107 PUBLICATION OF UTECH, JAMAICA 108 - 123 RESEARCH OR SCHOLARLY WORK IN THE POPULAR PRESS UTECH’S FLAGSHIP JOURNAL 124 CERDITS AND ACKNOWLEDGEMENTS 125 PAGE “EXCELLENCE THROUGH KNOWLEDGE” 4 A BRIEF HISTORY OF THE UNIVERSITY OF TECHNOLOGY, JAMAICA The University of Technology, Jamaica (UTech, Jamaica) started in 1958, as the Jamaica Institute of Technology. In 1959 the name of the institution was changed to the College of Arts, Science and Technology (CAST) Scheme of 1959. This was validated by an ACT of Parliament in 1964. In 1986, the CAST Scheme was revised in order to make the College a degree-granting institution, and the College became legally empowered to conduct affairs under a governing Council and Academic Board. The institution was formally accorded University status on September 1, 1995 as the University of Technology, Jamaica. The history of the institution is intimately connected with the social and economic development of Jamaica.
    [Show full text]